Ischemia and No Obstructive Coronary Artery Disease

Supplemental Digital Content is available in the text.

[1]  C. Berry,et al.  Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Function and CT Coronary Angiogram (CorCTCA) study , 2019, American heart journal.

[2]  J. Kastrup,et al.  Pro-inflammatory biomarkers in women with non-obstructive angina pectoris and coronary microvascular dysfunction , 2019, International journal of cardiology. Heart & vasculature.

[3]  Sean M. O'Brien,et al.  Baseline Characteristics and Risk Profiles of Participants in the ISCHEMIA Randomized Clinical Trial , 2019, JAMA cardiology.

[4]  Christopher J. Rush,et al.  Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.

[5]  B. Gersh,et al.  Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris , 2018, Circulation.

[6]  R. Tavella,et al.  Clinical and coronary haemodynamic determinants of recurrent chest pain in patients without obstructive coronary artery disease - A pilot study. , 2018, International journal of cardiology.

[7]  N. Sattar,et al.  Rationale and design of the British Heart Foundation (BHF) Coronary Microvascular Angina (CorMicA) stratified medicine clinical trial☆☆☆ , 2018, American heart journal.

[8]  Akshay S. Desai,et al.  Coronary microvascular dysfunction and future risk of heart failure with preserved ejection fraction , 2018, European heart journal.

[9]  P. Barlis,et al.  Physiological Predictors of Acute Coronary Syndromes: Emerging Insights From the Plaque to the Vulnerable Patient. , 2017, JACC. Cardiovascular interventions.

[10]  W. Fearon,et al.  Invasive Assessment of the Coronary Microvasculature: The Index of Microcirculatory Resistance , 2017, Circulation. Cardiovascular interventions.

[11]  E. Prescott,et al.  Sex-Related Differences in Vasomotor Function in Patients With Angina and Unobstructed Coronary Arteries. , 2017, Journal of the American College of Cardiology.

[12]  C. Berry,et al.  Stable coronary syndromes: pathophysiology, diagnostic advances and therapeutic need , 2017, Heart.

[13]  S. Miyata,et al.  1057Important prognostic impact of comorbid coronary microvascular dysfunction in patients with vasospastic angina , 2017 .

[14]  P. Libby,et al.  Ischemia and No Obstructive Coronary Artery Disease (INOCA): Developing Evidence-Based Therapies and Research Agenda for the Next Decade , 2017, Circulation.

[15]  E. V. van Beek,et al.  Symptoms and quality of life in patients with suspected angina undergoing CT coronary angiography: a randomised controlled trial , 2017, Heart.

[16]  J. Kastrup,et al.  Coronary Microvascular Function and Cardiovascular Risk Factors in Women With Angina Pectoris and No Obstructive Coronary Artery Disease: The iPOWER Study , 2016, Journal of the American Heart Association.

[17]  R Jay Widmer,et al.  Prevalence of Coronary Microvascular Dysfunction Among Patients With Chest Pain and Nonobstructive Coronary Artery Disease. , 2015, JACC. Cardiovascular interventions.

[18]  F. Crea,et al.  International standardization of diagnostic criteria for vasospastic angina , 2015, European heart journal.

[19]  O. Rimoldi,et al.  Effects of Sex on Coronary Microvascular Dysfunction and Cardiac Outcomes , 2014, Circulation.

[20]  Manesh R. Patel,et al.  Prevalence and predictors of nonobstructive coronary artery disease identified with coronary angiography in contemporary clinical practice. , 2014, American heart journal.

[21]  F. Crea,et al.  Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .

[22]  J. Kaski,et al.  Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.

[23]  Jeroen J. Bax,et al.  2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. , 2013, European heart journal.

[24]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, and the American College of Physicians, American Ass , 2012, Journal of the American College of Cardiology.

[25]  Sankey V. Williams,et al.  2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physi , 2012, Circulation.

[26]  Carl J Pepine,et al.  Coronary microvascular reactivity to adenosine predicts adverse outcome in women evaluated for suspected ischemia results from the National Heart, Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. , 2010, Journal of the American College of Cardiology.

[27]  Pamela S Douglas,et al.  Low diagnostic yield of elective coronary angiography. , 2010, The New England journal of medicine.

[28]  M. Woodward,et al.  Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) , 2005, Heart.

[29]  M. Delgado-Rodríguez,et al.  Bias , 2004, Journal of Epidemiology and Community Health.

[30]  A. Yeung,et al.  Novel Index for Invasively Assessing the Coronary Microcirculation , 2003, Circulation.

[31]  H. Fukuda,et al.  Clinical and angiographical characteristics of acetylcholine- induced spasm: relationship to dose of intracoronary injection of acetylcholine , 2002, Coronary artery disease.

[32]  F. N. van de Vosse,et al.  Coronary Thermodilution to Assess Flow Reserve: Validation in Humans , 2002, Circulation.

[33]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[34]  C von Birgelen,et al.  New signs characteristic of myocardial bridging demonstrated by intracoronary ultrasound and Doppler. , 1999, European heart journal.

[35]  A Bol,et al.  Coronary flow reserve calculated from pressure measurements in humans. Validation with positron emission tomography. , 1994, Circulation.

[36]  L. Melton,et al.  Influence of referral bias on the apparent clinical spectrum of infective endocarditis. , 1990, The American journal of medicine.

[37]  K. Okumura,et al.  Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. , 1988, Journal of the American College of Cardiology.

[38]  G. Rose,et al.  Self-administration of a questionnaire on chest pain and intermittent claudication. , 1977, British journal of preventive & social medicine.

[39]  Hiroaki Shimokawa,et al.  International standardization of diagnostic criteria for microvascular angina. , 2018, International journal of cardiology.

[40]  Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013). , 2014, Circulation journal : official journal of the Japanese Circulation Society.

[41]  B. Gersh,et al.  ESC guidelines on the management of stable coronary artery disease — addenda The Task Force on the management of stable coronary artery disease of the European Society of Cardiology , 2013 .